Multidimensional Evaluation of Patients With Ruptured or Unruptured Cerebral Aneurysm Undergoing Endovascular or Surgical Treatment
1 other identifier
observational
500
1 country
1
Brief Summary
Cerebral aneurysms are common changes in intracranial angioarchitecture. Unruptured aneurysms are increasingly identified thanks to the imaging techniques used in daily clinical practice. Since bleeding remains a highly dramatic event burdened by significant morbidity-mortality (about 50%), endovascular therapy, in combination with classic surgical therapy, is an essential element in contemporary medicine. Endovascular and surgical treatment represent the standard of care. The rationale of this study is to identify clinical and radiological characteristics, mainly neuro-radiological ones, not fully explored in previous studies, which can help predict the outcome of patients affected by cerebral aneurysm. The study will have the characteristics of a retrospective study on patients with cerebral aneurysm treated at our center from 1 January 2015 to 31 December 2023. Objective of the study is the multidimensional evaluation in patients with cerebral aneurysms, ruptured and unruptured, undergoing an endovascular embolization procedure or surgical treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2023
CompletedStudy Start
First participant enrolled
January 31, 2023
CompletedFirst Posted
Study publicly available on registry
February 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFebruary 8, 2023
February 1, 2023
5 months
January 26, 2023
February 6, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Functional independence at 90 days assessed by Rankin scale (mRS).
A good clinical outcome will be defined as an modified Rankin Scale (mRS) score between 0 and 2 (mRS 0 identifies a patients with no symptoms, 6 identifies a dead patient).
90 days
Secondary Outcomes (3)
efficacy of endovascular treatment using the Raymond-Roy scale
at the end of the endovascular procedure
90-day in-hospital mortality.
90 days
post-procedural symptomatic stroke/haemorrhage.
48 hours after the procedure
Interventions
* Endovascular embolization may be done with coils, remodeling technique (coils and balloon), stent and coils, flow-diverter, endosaccular devices. The access is through the femoral or radial artery. * Surgery is considered the standard neurosurgical procedure of aneurysm clipping.
Eligibility Criteria
Given the purely descriptive nature of the primary objective, we do not proceed with the formal calculation of the sample size but a sample of N=500 patients is proposed.
You may qualify if:
- age \> 18 years
- ruptured or unruptured cerebral aneurysm with consistent neurologic and radiologic evidence.
- CT without contrast medium and CT angiography, demonstrating the SAH and the aneurysm.
- Execution of an endovascular embolization procedure (which is indicated by a neurosurgeon and interventional neuroradiologist) or surgical treatment.
You may not qualify if:
- non-aneurysmal causes of SAH (example: AVMs, AVDs and trauma).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Policlinico Universitario A.Gemelli IRCCS
Roma, RM, 00168, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Neuroradiologist, MD MSc
Study Record Dates
First Submitted
January 26, 2023
First Posted
February 6, 2023
Study Start
January 31, 2023
Primary Completion
June 30, 2023
Study Completion
December 31, 2023
Last Updated
February 8, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share